Reuters logo
BRIEF-Atyr Pharma says ‍John Mendlein transitions from CEO to non-executive board member​
November 1, 2017 / 8:53 PM / a month ago

BRIEF-Atyr Pharma says ‍John Mendlein transitions from CEO to non-executive board member​

Nov 1 (Reuters) - Atyr Pharma Inc:

* Atyr Pharma announces leadership transition

* Atyr Pharma Inc - ‍John Mendlein transitions from CEO to non-executive board member​

* Atyr Pharma Inc - ‍Sanjay Shukla appointed president and CEO​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below